It converts these harmful substances into a form your body can safely excrete via urine or bile
For patients who want the clinical benefits of a GLP-1 without a weekly injection or complicated dosing requirements, it's a meaningful option
Third, it focuses attention on the tolerability challenge: greater potency appears to come with a higher side effect burden, and the field must determine how to preserve efficacy while improving patient retention [5]
[DOI] [PubMed] [Google Scholar] 137.Jastreboff A.M., le Roux C.W., Stefanski A., Aronne L.J., Halpern B., Wharton S., Wilding J.P.H., Perreault L., Zhang S., Battula R., et al
In clinical trials, patients taking semaglutide GLP-1 over 68 weeks have been able to achieve weight loss of up to 10 to 20% of their total body weight
Shane Speights, dean of the NYIT School of Osteopathic Medicine at Arkansas State University